cmAngio® vs physIQ Heart Rhythm and Respiratory Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS

AI Verdict

Tool A focuses on identifying Breast Arterial Calcifications from mammograms to assess cardiovascular risk in women. Tool B, conversely, utilizes continuous wearable biosensor data to provide personalized physiological analytics, detecting subtle changes in heart rhythm and respiration for real-time monitoring. While both contribute to cardiovascular health insights, they do so through distinct data sources and clinical applications, making them adjacent rather than direct competitors.

Choose cmAngio® if…

Choose cmAngio® if your primary objective is to integrate cardiovascular risk assessment into routine breast cancer screening workflows. This AI-powered tool is ideal for leveraging existing mammogram data to detect Breast Arterial Calcifications (BAC), providing valuable insights into a woman's cardiovascular health without requiring additional radiation or procedures. It is best suited for radiology departments and women's health centers aiming to enhance preventive care by identifying early indicators of cardiovascular risk during standard mammography appointments.

View cmAngio® →

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if you need continuous, real-time remote monitoring of patients using wearable biosensors to detect subtle physiological changes and early signs of decompensation. This platform is particularly well-suited for managing patients with known or suspected cardiac and respiratory conditions, enabling personalized baseline learning and proactive intervention based on continuous data streams for heart rate, heart rate variability, atrial fibrillation, and respiration rate. It's an excellent choice for remote patient monitoring programs focused on preventing acute events and optimizing patient management outside of traditional clinical settings.

View physIQ Heart Rhythm and Respiratory Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® physIQ Heart Rhythm and Respiratory Module
Pricing Paid, out-of-pocket Contact for pricing
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® physIQ Heart Rhythm and Respiratory Module
Primary Function/Focus Detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. Generating unprecedented health insight using continuous wearable biosensor data and advanced analytics, with a focus on heart rhythm and respiratory monitoring.
Data Input Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams (DICOM-compliant viewer compatible). Continuous wearable biosensor data.
Key Detections/Analytics AI-based detection of Breast Arterial Calcifications (BAC), visualization of BAC location on a scorecard. AI-based personalized physiology analytics, detects subtle physiological changes and early signs of decompensation, calculates heart rate and heart rate variability, detects atrial fibrillation, determines respiration rate.
Categories Cardiology AI, OB/GYN AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Critical Care, Pulmonology

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and physIQ Heart Rhythm and Respiratory Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngio analyzes Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams to detect Breast Arterial Calcifications (BAC). In contrast, physIQ's module continuously collects and processes data from wearable biosensors, specifically single-lead ECG signals and triaxial accelerometer data, to generate health insights.
cmAngio provides insights into cardiovascular health by detecting and visualizing Breast Arterial Calcifications (BAC) on mammograms, aiding early risk assessment for conditions like arteriosclerosis. physIQ's module detects atrial fibrillation, calculates heart rate and respiration rate, and identifies subtle physiological changes and early signs of decompensation.
cmAngio is designed for use in Cardiology, Obstetrics & Gynecology, and Radiology, primarily for women's health and cardiovascular risk assessment. physIQ's module is relevant for Cardiology, Critical Care, and Pulmonology specialties, focusing on continuous remote patient monitoring.
cmAngio identifies Breast Arterial Calcifications on existing mammograms, enabling identification and reporting without additional radiation or procedures. physIQ utilizes continuous data from non-invasive wearable biosensors to provide personalized physiological insights, avoiding the need for invasive procedures.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.